Number | Ticker | Country | Founded | IPO Year | Price | Revenue | Analyst Decision | Analyst Count |
---|---|---|---|---|---|---|---|---|
1 | GTNGray Television Inc. | United States | 1897 | N/A | $3.07 | $3,463,000,000.00 | Buy | 4 |
2 | TLSTelos Corporation | United States | 1969 | 2020 | $3.37 | $122,959,000.00 | Buy | 6 |
3 | SLRNACELYRIN INC. | United States | 2020 | 2023 | $3.18 | $0.00 | Buy | 4 |
4 | LUCDLucid Diagnostics Inc. | United States | 2018 | 2021 | $0.78 | $4,189,000.00 | Strong Buy | 4 |
5 | ASRTAssertio Holdings Inc. | United States | 1995 | 1997 | $0.85 | $125,763,000.00 | Strong Buy | 4 |
6 | VSTMVerastem Inc. | United States | 2010 | 2012 | $3.96 | $10,000,000.00 | Strong Buy | 8 |
7 | XOSXos Inc. | United States | 2016 | N/A | $3.12 | $62,863,000.00 | Buy | 5 |
8 | STROSutro Biopharma Inc. | United States | 2003 | 2018 | $1.87 | $160,955,000.00 | Strong Buy | 7 |
9 | CRVSCorvus Pharmaceuticals Inc. | United States | 2014 | 2016 | $4.55 | $0.00 | Buy | 4 |
10 | BITFBitfarms Ltd. | Canada | 2017 | N/A | $1.59 | $182,959,000.00 | Strong Buy | 7 |
11 | INOInovio Pharmaceuticals Inc. | United States | 1979 | 1998 | $1.79 | $203,413.00 | Buy | 6 |
12 | BRFSBRF S.A. | Brazil | 1934 | 2000 | $4.23 | $10,698,616,606.00 | Buy | 4 |
13 | HIVEHIVE Digital Technologies Ltd. | Canada | 1987 | N/A | $2.97 | $123,022,000.00 | Strong Buy | 6 |
14 | AQSTAquestive Therapeutics Inc. | United States | 2004 | 2018 | $3.59 | $58,900,000.00 | Strong Buy | 8 |
15 | ERASErasca Inc. | United States | 2018 | 2021 | $2.48 | $0.00 | Strong Buy | 5 |
16 | ATAIATAI Life Sciences N.V. | Germany | 2018 | 2021 | $1.20 | $331,000.00 | Strong Buy | 4 |
17 | MURAMural Oncology plc | Ireland | 2013 | N/A | $3.29 | $0.00 | Strong Buy | 4 |
18 | TALKTalkspace Inc. | United States | 2012 | N/A | $3.00 | $181,291,000.00 | Buy | 5 |
19 | QTTBQ32 Bio Inc. Common Stock | United States | 2015 | N/A | $3.23 | -$14,662,000.00 | Buy | 8 |
20 | CNTYCentury Casinos Inc. | United States | 1992 | 1993 | $3.06 | $581,905,000.00 | Strong Buy | 4 |
21 | ALECAlector Inc. | United States | 2013 | 2019 | $1.92 | $61,508,000.00 | Buy | 6 |
22 | NGDNew Gold Inc. | Canada | N/A | 2004 | $2.52 | $861,500,000.00 | Buy | 4 |
23 | FHTXFoghorn Therapeutics Inc. | United States | 2015 | 2020 | $4.93 | $25,515,000.00 | Strong Buy | 5 |
24 | BMEABiomea Fusion Inc. | United States | 2017 | 2021 | $4.03 | $0.00 | Buy | 13 |
25 | EDITEditas Medicine Inc. | United States | 2013 | 2016 | $1.25 | $61,759,000.00 | Buy | 14 |
26 | ABSIAbsci Corporation | United States | 2011 | 2021 | $2.93 | $4,207,000.00 | Strong Buy | 6 |
27 | COOKTraeger Inc. | United States | 1985 | 2021 | $2.45 | $598,914,000.00 | Buy | 5 |
28 | ACHVAchieve Life Sciences Inc. | Canada | N/A | N/A | $3.78 | $0.00 | Strong Buy | 5 |
29 | OBIOOrchestra BioMed Holdings Inc. | United States | 2017 | N/A | $4.69 | $2,647,000.00 | Strong Buy | 4 |
30 | CRBUCaribou Biosciences Inc. | United States | 2011 | 2021 | $1.79 | $11,475,000.00 | Strong Buy | 4 |
31 | CCOClear Channel Outdoor Holdings Inc. | United States | 1995 | 2005 | $1.38 | $2,231,395,000.00 | Buy | 4 |
32 | APLTApplied Therapeutics Inc. | United States | 2016 | 2019 | $0.87 | -$212,000.00 | Buy | 7 |
33 | ABUSArbutus Biopharma Corporation | United States | N/A | N/A | $3.19 | $6,742,000.00 | Strong Buy | 4 |
34 | ABOSAcumen Pharmaceuticals Inc. | United States | 1996 | 2021 | $1.77 | $0.00 | Strong Buy | 4 |
35 | ANGIAngi Inc. | United States | 2017 | 2017 | $1.65 | $1,217,676,000.00 | Buy | 9 |
36 | EVGOEVgo Inc. | United States | 2010 | N/A | $4.25 | $239,306,000.00 | Strong Buy | 10 |
37 | TSVT2seventy bio Inc. | United States | 2021 | N/A | $2.99 | $45,620,000.00 | Buy | 6 |
38 | LRMRLarimar Therapeutics Inc. | United States | N/A | N/A | $3.96 | $0.00 | Strong Buy | 8 |
39 | ADAPAdaptimmune Therapeutics plc | United Kingdom | 2008 | 2015 | $0.59 | $175,041,000.00 | Strong Buy | 4 |
40 | ANVSAnnovis Bio Inc. | United States | 2008 | 2020 | $4.46 | $0.00 | Strong Buy | 6 |
41 | TVGrupo Televisa S.A. | Mexico | 1969 | 1993 | $1.77 | $3,622,556,115.00 | Buy | 5 |
42 | AMLXAmylyx Pharmaceuticals Inc. | United States | 2014 | 2022 | $4.07 | $196,485,000.00 | Buy | 7 |
43 | CLSDClearside Biomedical Inc. | United States | 2011 | 2016 | $0.88 | $7,703,000.00 | Strong Buy | 6 |
44 | GNLXGenelux Corporation | United States | 2001 | 2023 | $2.30 | $8,000.00 | Strong Buy | 4 |
45 | BYONBeyond Inc. | United States | 1997 | N/A | $4.85 | $1,476,271,000.00 | Buy | 10 |
46 | RZLTRezolute Inc. (NV) | United States | 2010 | N/A | $4.44 | $0.00 | Strong Buy | 8 |
47 | GOEVCanoo Inc. | United States | 2017 | N/A | $0.08 | $1,864,000.00 | Strong Buy | 6 |
48 | BEEMBeam Global | United States | 2006 | N/A | $2.87 | $60,883,000.00 | Strong Buy | 4 |
49 | PRQRProQR Therapeutics N.V. | Netherlands | 2012 | 2014 | $2.67 | $20,506,357.00 | Strong Buy | 5 |
50 | MREOMereo BioPharma Group plc | United Kingdom | 2015 | N/A | $3.39 | $1,000,000.00 | Strong Buy | 5 |
The FinQuota filters have identified what they believe to be the "Best Under $5 Stocks to Buy on December 24, 2024" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.